Paroxetine hydrochloride 是选择性5-羟色胺重吸收抑制剂(SSRI)。
Paroxetine HCl is an antidepressant drug of the SSRI type.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Le Poul E, et al. Naunyn Schmiedebergs Arch Pharmacol, 1995, 352(2), 141-148.
分子式 C19H21ClFNO3 |
分子量 365.83 |
CAS号 78246-49-8 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 74 mg/mL |
Water 10 mg/mL |
Ethanol 35 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00841659 | Healthy | Drug: Paroxetine HCl|Drug: Paxil | Teva Pharmaceuticals USA | Phase 1 | 2002-08-01 | 2009-09-09 |
NCT00841698 | Healthy | Drug: Paroxetine HCl|Drug: Paxil | Teva Pharmaceuticals USA | Phase 1 | 2002-10-01 | 2009-09-09 |
NCT01841502 | Hepatitis C Infection|Depression | Drug: Paroxetine|Drug: telaprevir | Radboud University|Janssen, LP | Phase 2 | 2013-05-01 | 2014-10-27 |
NCT00749359 | Depressive Disorder | Drug: Paxil CR | GlaxoSmithKline | Phase 1 | 2008-07-01 | 2016-11-04 |
NCT01829919 | Postmenopausal Symptoms | Drug: Brisdelle (paroxetine mesylate) | Noven Therapeutics | Phase 1 | 2011-07-01 | 2015-10-14 |
NCT00184106 | Phobic Disorders | Drug: Seroxat, Cognitive therapy, Seroxat+ cognitive therapy | Norwegian University of Science and Technology|St. Olavs Hospital | Phase 4 | 2004-10-01 | 2017-02-23 |
NCT00610610 | Fibromyalgia Syndrome | Drug: Paroxetine CR|Drug: Placebo | Duke University|GlaxoSmithKline | Phase 4 | 2002-01-01 | 2013-06-19 |
NCT01000857 | Depressive Disorder | Drug: Paroxetine CR and Paroxetine IR | GlaxoSmithKline | Phase 1 | 2009-11-01 | 2017-01-25 |
NCT00406003 | Pharmacokinetics|Depressive Disorder | Drug: Paroxetine controlled Release 12.5mg, 25mg and37.5mg | GlaxoSmithKline | Phase 1 | 2006-03-01 | 2012-05-31 |
NCT00812812 | Depressive Disorder | Drug: paroxetine 10mg tablet|Drug: paroxetine 20mg tablet|Drug: matched placebo to paroxetine 10mg|Drug: matched placebo to paroxetine 20mg | GlaxoSmithKline | Phase 4 | 2009-03-01 | 2016-11-29 |
NCT00225914 | Menopause | Drug: Paroxetine|Drug: placebo | Massachusetts General Hospital|GlaxoSmithKline | Phase 4 | 2004-09-01 | 2010-11-23 |
NCT01159821 | Healthy | Drug: 31001074/paroxetine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 1 | 2010-08-01 | 2014-04-07 |
NCT02681198 | Healthy | Drug: Lofexidine|Drug: Paroxetine | US WorldMeds LLC|National Institute on Drug Abuse (NIDA) | Phase 1 | 2016-02-01 | 2016-10-31 |
NCT01361308 | Postmenopausal Symptoms | Drug: Brisdelle (paroxetine mesylate)|Drug: Placebo capsules | Noven Therapeutics | Phase 3 | 2011-05-01 | 2015-10-14 |
NCT01376271 | Social Phobia | Drug: Paroxetine | GlaxoSmithKline | 2010-01-01 | 2014-06-30 | |
NCT01101841 | Hot Flashes | Drug: Brisdelle (paroxetine mesylate)|Drug: Placebo capsules | Noven Therapeutics | Phase 3 | 2010-03-01 | 2015-10-14 |
NCT00560612 | Stress Disorders, Post-Traumatic | Drug: Paroxetine|Drug: Placebo | Durham VA Medical Center | Phase 4 | 2006-01-01 | 2011-03-31 |
NCT00786188 | Hot Flashes | Drug: Brisdelle (paroxetine mesylate)|Drug: Sugar pill | Noven Therapeutics | Phase 2 | 2008-11-01 | 2015-10-14 |
NCT00620581 | Premenstrual Dysphoric Disorder | Drug: Paroxetine | Hamilton Health Sciences Corporation|McMaster University | Phase 3 | 2008-02-07 | |
NCT01376128 | Panic Disorder | Drug: Paroxetine | GlaxoSmithKline | 2008-03-01 | 2011-06-16 | |
NCT00767754 | Panic Disorder | Drug: Paxil CR | Samsung Medical Center | Phase 4 | 2007-01-01 | 2011-07-21 |
NCT00259883 | Mental Disorders | Drug: paroxetine | GlaxoSmithKline | Phase 4 | 2005-06-01 | 2017-01-16 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们